β-Methyltryptamine
| βMT, BMT | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 174.24 g/mol [1] |
| Predicted LogP | 1.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H14N2 |
| IUPAC name | 2-(1H-indol-3-yl)propan-1-amine |
| SMILES | CC(CN)C1=CNC2=CC=CC=C21 |
| InChI | InChI=1S/C11H14N2/c1-8(6-12)10-7-13-11-5-3-2-4-9(10)11/h2-5,7-8,13H,6,12H2,1H3 |
| InChIKey | UNUICNBHOJTXMS-UHFFFAOYSA-N |
| CAS number | 4765-22-4 |
| PubChem CID | 6452095 |
β-Methyltryptamine (also known as 1H-Indole-3-ethanamine, β-methyl-, 2-(1H-indol-3-yl)propylamine, 2-(1 H-indol-3-yl)propylamine, 2-(1H-Indol-3-yl)-propylamine, Pdsp1_000948, Pdsp2_000934, F2147-2880 or beta-Methyltryptamine) is a substance of the β-alkyltryptamine class.
Chemistry
Stereochemistry []
β-Methyltryptamine is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
β-Methyltryptamine matches Lipinski's rule of five.See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 6452095, β-Methyltryptamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/6452095
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 14:59:50 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 14:59:46 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 14:59:46 |
| gsrs | missing (no UNII) | 2026-11-20 14:59:46 |
| hmdb | missing (no HMDB id) | 2026-11-20 14:59:46 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 14:59:51 |
| pubchem | ok | 2026-11-20 14:59:44 |
| missing (no r/tripreports posts mention it) | 2026-11-20 14:59:46 | |
| sider | missing (not in SIDER) | 2026-11-20 14:59:46 |
| structure | ok | 2026-11-20 14:59:46 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 14:59:46 |